Indeed, vascular endothelial growth factor (VEGF) is known to play a crucial role in tumor microenvironment immuno-modulation and anti-angiogenic treatment has been proposed as an effective modality to potentiate immunotherapy[93]. The gene discussed is VEGFA; the disease is neoplasm.